These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31658642)

  • 1. Effect of Polymer Permeability and Solvent Removal Rate on
    Zhang X; Yang L; Zhang C; Liu D; Meng S; Zhang W; Meng S
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31658642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.
    Wang L; Wang A; Zhao X; Liu X; Wang D; Sun F; Li Y
    Int J Pharm; 2012 May; 427(2):284-92. PubMed ID: 22387369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems.
    Liu H; Venkatraman SS
    J Pharm Sci; 2012 May; 101(5):1783-93. PubMed ID: 22318766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release.
    Parent M; Nouvel C; Koerber M; Sapin A; Maincent P; Boudier A
    J Control Release; 2013 Nov; 172(1):292-304. PubMed ID: 24001947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.
    Liu Q; Zhang H; Zhou G; Xie S; Zou H; Yu Y; Li G; Sun D; Zhang G; Lu Y; Zhong Y
    Int J Pharm; 2010 Sep; 397(1-2):122-9. PubMed ID: 20650309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery.
    Yehia SA; Elshafeey AH; Elsayed I
    J Liposome Res; 2012 Jun; 22(2):128-38. PubMed ID: 22091557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
    Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Drug Physicochemical Properties on In-Situ Forming Implant Polymer Degradation and Drug Release Kinetics.
    Joiner JB; Prasher A; Young IC; Kim J; Shrivastava R; Maturavongsadit P; Benhabbour SR
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant.
    Yu Y; Ngo HV; Jin G; Tran PHL; Tran TTD; Nguyen VH; Park C; Lee BJ
    Int J Nanomedicine; 2021; 16():2819-2831. PubMed ID: 33888982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY; Körber M; López Esguerra V; Bodmeier R
    J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid/Hollow depots for drug delivery, part 1: effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release.
    Liu H; Venkatraman SS
    J Pharm Sci; 2014 Feb; 103(2):485-95. PubMed ID: 24357252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of implant formation on drug release kinetics of in situ forming implants.
    Suh MS; Kastellorizios M; Tipnis N; Zou Y; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2021 Jan; 592():120105. PubMed ID: 33232755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems.
    Liu H; Venkatraman SS
    J Biomater Sci Polym Ed; 2012; 23(1-4):251-66. PubMed ID: 21244721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvent exchange and drug release characteristics of doxycycline hyclate-loaded bleached shellac in situ-forming gel and -microparticle.
    Phaechamud T; Senarat S; Puyathorn N; Praphanwittaya P
    Int J Biol Macromol; 2019 Aug; 135():1261-1272. PubMed ID: 30448493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants.
    Li Z; Mu H; Weng Larsen S; Jensen H; Østergaard J
    Int J Pharm; 2021 Nov; 609():121183. PubMed ID: 34653562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.